Advaxis Lead Product Candidate ADXS-HPV in Combination with PD-1 Antibody … – DailyFinance

Advaxis Lead Product Candidate ADXS-HPV in Combination with PD-1 Antibody
DailyFinance
PRINCETON, N.J.–(BUSINESS WIRE)– Advaxis, Inc. (OTCQB: ADXS) ("Advaxis" or the "Company"), a leader in developing the next generation of immunotherapies for cancer and infectious diseases,announced the publication of preclinical research with 
Advaxis Announces Publication Of Preclinical Research With ADXS-HPVRTT News

all 2 news articles »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *